Table 2. Effects of any exposure to intervention (regardless of duration), with and without adjustment for baseline values of outcome*.
| Outcomes | Not adjusted for baseline | Adjusted for baseline† | ||||
|---|---|---|---|---|---|---|
| OR | 95% CI | P value | OR | 95% CI | P value | |
| Individuals with asthma | ||||||
| Start or change in treatment | 1.26 | 0.99 to 1.60 | 0.064 | 1.29 | 1.02 to 1.64 | 0.033 |
| Spirometry ordered | 1.64 | 1.29 to 2.10 | <0.001 | 1.55 | 1.22 to 1.97 | <0.001 |
| Individuals with COPD | ||||||
| Start or change in treatment | 1.07 | 0.79 to 1.44 | 0.671 | 1.05 | 0.80 to 1.37 | 0.729 |
| Spirometry ordered | 1.53 | 1.17 to 2.01 | 0.002 | 1.50 | 1.15 to 1.96 | 0.003 |
| All Individuals | ||||||
| New cardiovascular diagnosis | 1.14 | 0.95 to 1.36 | 0.157 | 1.14 | 0.95 to 1.36 | 0.159 |
| Any cardiovascular risk test | 0.86 | 0.76 to 0.99 | 0.031 | 0.86 | 0.76 to 0.98 | 0.023 |
| New antidepressant | 1.22 | 0.94 to 1.58 | 0.127 | 1.18 | 0.92 to 1.52 | 0.193 |
Mixed effect logistic regression models, adjusted for randomisation stratum.
Also adjusted for mean clinic level baselines values of respective outcome variable.
COPD, chronic obstructive pulmonary disease.